Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spots

被引:23
作者
Hong, Xinying [1 ]
Daiker, Jessica [1 ]
Sadilek, Martin [1 ]
DeBarber, Andrea E. [2 ]
Chiang, John [3 ]
Duan, Jie [3 ]
Bootsma, Albert H. [4 ]
Huidekoper, Hidde H. [5 ]
Vaz, Frederic M. [4 ]
Gelb, Michael H. [1 ,6 ]
机构
[1] Univ Washington, Dept Chem, Seattle, WA 98195 USA
[2] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA
[3] Mol Vis Lab, Hillsboro, OR USA
[4] Univ Amsterdam, Lab Genet Metab Dis, Amsterdam UMC, Dept Clin Chem,Amsterdam Gastroenterol & Metab,Lo, Amsterdam, Netherlands
[5] Univ Med Ctr Rotterdam, Ctr Lysosomal & Metab Dis, Erasmus Med Ctr, Dept Pediat, Rotterdam, Netherlands
[6] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
cerebrotendinous xanthomatosis; newborn screening; biomarker; biomarker ratio; BILE-ACIDS; DIAGNOSIS;
D O I
10.1038/s41436-020-0846-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose Cerebrotendinous xanthomatosis (CTX) is a treatable hereditary disorder caused by the deficiency of sterol 27-hydroxylase, which is encoded by theCYP27A1gene. Different newborn screening biomarkers for CTX have been described, including 7 alpha,12 alpha-dihydroxy-4-cholesten-3-one (7 alpha 12 alpha C4), 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol glucuronide (GlcA-tetrol), the ratio of GlcA-tetrol to tauro-chenodeoxycholic acid (t-CDCA) (GlcA-tetrol/t-CDCA), and the ratio of tauro-trihydroxycholestanoic acid (t-THCA) to GlcA-tetrol (t-THCA/GlcA-tetrol). We set out to evaluate these screening methods in a research study using over 32,000 newborn dried blood spots (DBS). Methods Metabolites were extracted from DBS with methanol containing internal standard, which was then quantified by ultraperformance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Results The measurement of 7 alpha 12 alpha C4 was complicated by isobaric interferences and was discontinued. A total of 32,737 newborns were screened based on the GlcA-tetrol concentration in DBS. GlcA-tetrol/t-CDCA and t-THCA/GlcA-tetrol ratios were also calculated. Newborns displaying both elevated GlcA-tetrol and GlcA-tetrol/t-CDCA ratio were considered to be screen positives. The t-THCA/GlcA-tetrol ratio was used to further distinguish CTX screen positives from Zellweger Spectrum Disorder (ZSD) screen positives. Only one newborn displayed both elevated GlcA-tetrol concentration in DBS and a typical CTX biochemical profile. This newborn was interpreted as a CTX-affected patient asCYP27A1gene sequencing identified two known pathogenic variants. Conclusion The results indicate that both GlcA-tetrol and the GlcA-tetrol/t-CDCA ratio are excellent CTX biomarkers suitable for newborn screening. By characterizing the relationship of GlcA-tetrol, t-CDCA, and t-THCA as secondary markers, 100% assay specificity can be achieved.
引用
收藏
页码:1606 / 1612
页数:7
相关论文
共 19 条
[1]   Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ∼60,000 human exomes [J].
Appadurai, Vivek ;
DeBarber, Andrea ;
Chiang, Pei-Wen ;
Patel, Shailendra B. ;
Steiner, Robert D. ;
Tyler, Charles ;
Bonnen, Penelope E. .
MOLECULAR GENETICS AND METABOLISM, 2015, 116 (04) :298-304
[2]  
Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49
[3]   Chronic Diarrhea and Juvenile Cataracts: Think Cerebrotendinous Xanthomatosis and Treat [J].
Berginer, Vladimir M. ;
Gross, Bella ;
Morad, Khayat ;
Kfir, Nechama ;
Morkos, Siman ;
Aaref, Salameh ;
Falik-Zaccai, Tzipora C. .
PEDIATRICS, 2009, 123 (01) :143-147
[4]   Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience [J].
Burton, Barbara K. ;
Charrow, Joel ;
Hoganson, George E. ;
Waggoner, Darrell ;
Tinkle, Brad ;
Braddock, Stephen R. ;
Schneider, Michael ;
Grange, Dorothy K. ;
Nash, Claudia ;
Shryock, Heather ;
Barnett, Rebecca ;
Shao, Rong ;
Basheeruddin, Khaja ;
Dizikes, George .
JOURNAL OF PEDIATRICS, 2017, 190 :130-135
[5]   Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment [J].
DeBarber, Andrea E. ;
Kalfon, Limor ;
Fedida, Ayalla ;
Sheffer, Vered Fleisher ;
Ben Haroush, Shani ;
Chasnyk, Natalia ;
Biton, Efrat Shuster ;
Mandel, Hanna ;
Jeffries, Krystal ;
Shinwell, Eric S. ;
Falik-Zaccai, Tzipora C. .
JOURNAL OF LIPID RESEARCH, 2018, 59 (11) :2214-2222
[6]   A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns [J].
DeBarber, Andrea E. ;
Luo, Jenny ;
Star-Weinstock, Michal ;
Purkayastha, Subhasish ;
Geraghty, Michael T. ;
Chiang, John ;
Merkens, Louise S. ;
Pappu, Anuradha S. ;
Steiner, Robert D. .
JOURNAL OF LIPID RESEARCH, 2014, 55 (01) :146-154
[7]   Severe Neonatal Cholestasis in Cerebrotendinous Xanthomatosis: Genetics, Immunostaining, Mass Spectrometry [J].
Gong, Jing-Yu ;
Setchell, Kenneth D. R. ;
Zhao, Jing ;
Zhang, Wujuan ;
Wolfe, Brian ;
Lu, Yi ;
Lackner, Karolin ;
Knisely, A. S. ;
Wang, Neng-Li ;
Hao, Chen-Zhi ;
Zhang, Mei-Hong ;
Wang, Jian-She .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 65 (05) :561-568
[8]   DIAGNOSIS OF ZELLWEGER SYNDROME BY ANALYSIS OF BILE-ACIDS AND PLASMALOGENS IN STORED DRIED BLOOD COLLECTED AT NEONATAL SCREENING [J].
GUSTAFSSON, J ;
SISFONTES, L ;
BJORKHEM, I .
JOURNAL OF PEDIATRICS, 1987, 111 (02) :264-267
[9]   Incidence of 4 Lysosomal Storage Disorders From 4 Years of Newborn Screening [J].
Hopkins, Patrick V. ;
Klug, Tracy ;
Vermette, Lacey ;
Raburn-Miller, Julie ;
Kiesling, Jami ;
Rogers, Sharmini .
JAMA PEDIATRICS, 2018, 172 (07) :696-697
[10]   Reference ranges of serum bile acids in children and adolescents [J].
Jahnel, Joerg ;
Zoehrer, Evelyn ;
Scharnagl, Hubert ;
Erwa, Wolfgang ;
Fauler, Guenter ;
Stojakovic, Tatjana .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (11) :1807-1813